You searched for: pužni transporter (Kroatiska - Engelska)

oct2 je transporter odgovoran za aktivno izlučivanje fampridina.
oct2 is the transporter responsible for the active secretion of fampridine.

pomagnite nagibni transporter pri komori za oblikovanje u donji položaj pomoću lokalnih gumba.
move tilting conveyor at forming chamber to lower position by using the local buttons.

lesinurad također inhibira oat4, transporter mokraćne kiseline uključen u hiperuricemiju uzrokovanu diuretikom.
lesinurad also inhibits oat4, a uric acid transporter involved in diuretic-induced hyperuricaemia.

lesinurad je selektivni inhibitor ponovne apsorpcije mokraćne kiseline koji inhibira transporter mokraćne kiseline urat1.
lesinurad is a selective uric acid reabsorption inhibitor that inhibits uric acid transporter urat1.

tariranje sekundarne vage moguće je samo ako je vaga prazna, a transporter sekundarne vage radi pri najmanje 15 m/min.
tare the secondary scale is only possible if scale is empty, clean and secondary scale conveyor runs at least 15 m/min.

tariranje primarne vage moguće je samo ako je vaga prazna i čista, a transporter primarne vage radi pri najmanje 70m/min.
tare the primary scale is only possible if scale is empty, clean and primary scale conveyor runs at least 70m/min.

lurasidon in vitro inhibira efluks transporter p-gp te se kliničko značanje inhibicije crijevnog p-gp ne može isključiti.
lurasidone is an in vitro inhibitor of the efflux transporter p-gp and the clinical relevance of intestinal p-gp inhibition cannot be excluded.

međunarodnom proljetnom sajmu u gudovcu , tvrtka “ hittner ” predstavila je ecotrac 30 transporter - novi …
international spring fair in gudovac “ hittner” presented the ecotrac 30 transporter - a new…

in vitro je pokazano da glavni metaboliti abirateronsulfat i n-oksid abirateronsulfat inhibiraju oatp1b1 transporter unosa u jetru što posljedično može povisiti koncentracije lijekova koji se eliminiraju putem oatp1b1.
in vitro, the major metabolites abiraterone sulphate and n-oxide abiraterone sulphate were shown to inhibit the hepatic uptake transporter oatp1b1 and as a consequence it may increase the concentrations of medicinal products eliminated by oatp1b1.

smanjena funkcija jetrenih transportnih proteina oatp (polipeptidni transporter anorganskih aniona) može povećati sistemsku izloženost simvastatinu i povećati rizik od miopatije i rabdomiolize.
reduced function of hepatic oatp transport proteins can increase the systemic exposure of simvastatin and increase the risk of myopathy and rhabdomyolysis.

treba očekivati povećanje plazmatskih koncentracija supstrata za efluksni transporter p-gp, poput digoksina ili dabigatrana (vidjeti tablicu 2).
an increase in plasma concentrations of substrates of the p-gp efflux transporter, such as digoxin or dabigatran, should be anticipated (see table 2).

lumakaftor i ivakaftor nisu inhibitori prijenosnika oatp1b1, oatp1b3 i prijenosnika organskih kationa (engl. organic cation transporter - oct) 1 i 2.
lumacaftor and ivacaftor are not inhibitors of oatp1b1, oatp1b3, and organic cation transporter (oct) 1 and 2.

na temelju in vitro podataka, ceritinib ne inhibira apikalni efluksni transporter mrp2, transportere unosa u jetru oatp1b1 ili oatp1b3, bubrežne transportere za unos organskih aniona oat1 i oat3, ili transportere za unos organskih kationa oct1 ili oct2 pri klinički relevantnim koncentracijama.
based on in vitro data, ceritinib does not inhibit apical efflux transporter mrp2, hepatic uptake transporters oatp1b1 or oatp1b3, renal organic anion uptake transporters oat1 and oat3, or the organic cation uptake transporters oct1 or oct2 at clinically relevant concentrations.

preklopite na zaslon "transporter sekundarne vage" preko zaslona "pregled sekundarne linije" (f11 -> f7).
switch to “secondary scale conveyor” screen via “secondary line overview” screen (f11 -> f7).